Related Experiment Video

Updated: Jul 6, 2026

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

[Atypical infection of the respiratory tract and bronchial asthma]

Karina Jahnz-Rózyk, Tomasz Targowski

    Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
    |March 26, 2008
    PubMed

    Insights

    Diagnosing atypical bacterial pneumonia is challenging. While macrolides show promise for asthma management due to anti-inflammatory effects, more research is needed to confirm their efficacy.

    Area of Science:

    • Pulmonology and Infectious Diseases
    • Microbiology

    Background:

    • Community-acquired pneumonia (CAP) is a significant cause of illness and death.
    • Atypical bacteria like Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila are key pathogens in CAP.
    • Diagnosing these atypical infections is difficult due to non-specific clinical signs and limited detection methods.

    Discussion:

    • The link between atypical bacterial infections and asthma pathogenesis is under ongoing investigation.
    • Macrolides possess both antimicrobial and anti-inflammatory properties, suggesting potential benefits for asthma.
    • Current evidence is insufficient to definitively recommend macrolides for chronic asthma management.

    Key Insights:

    • Atypical bacterial infections pose diagnostic challenges in community-acquired pneumonia.
    • Macrolides' dual action may benefit asthma patients by reducing airway inflammation.
    • There is a need for robust studies to clarify the role of atypical bacteria and macrolides in asthma.

    Outlook:

    • Further research is crucial to establish the role of atypical bacterial infections in asthma.
    • Well-designed clinical trials are required to evaluate macrolide therapy in asthma management.
    • Investigating the interplay between atypical pathogens and asthma could lead to novel therapeutic strategies.

    More Related Videos

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

    Published on: November 4, 2010

    Related Concept Videos

    Asthma I: Introduction01:28

    Asthma I: Introduction

    Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Asthma-I: Introduction01:29

    Asthma-I: Introduction

    Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
    Asthma: Pathogenesis and Management01:20

    Asthma: Pathogenesis and Management

    Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
    Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
    Asthma-II: Pathophysiology and Classification01:26

    Asthma-II: Pathophysiology and Classification

    Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
    Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
    Critical processes in asthma pathophysiology include:
    Microbiota of the Respiratory Tract01:29

    Microbiota of the Respiratory Tract

    The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...